[Analyzing clinical character of patients resistant to lamivudine with chronic hepatitis B with YMDD mutations or non-YMDD mutations].
Yang
Dan-hong
DH
Department of Infectious Disease, Zhejiang Provincial Hospital, Hangzhou 310016, China.
Xie
Yuan-jun
YJ
Liang
Wei-feng
WF
Zhao
Nian-feng
NF
D000998:Antiviral Agents / Q000627:therapeutic use; D004252:DNA Mutational Analysis; D004279:DNA, Viral / Q000097:blood; D024882:Drug Resistance, Viral / Q000235:genetics*; D005260:Female; D006515:Hepatitis B virus / Q000187:drug effects / Q000235:genetics*; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use
D000998:Antiviral Agents; D004279:DNA, Viral; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine